Carolina Research Center

Shelby, North Carolina 28150-3803

2 studies enrolling now · 10 studies all time

What they study most

COVID-19, Cardiovascular Diseases, Chronic Kidney Disease, Chronic Obstructive Pulmonary Disease, Diabetic Kidney Disease, Obesity, Osteoarthritis, Osteoarthritis, Hip, Osteoarthritis, Knee, Overweight, Overweight or Obesity, Respiratory Syncytial Virus

Studies at this site

• A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee — Recruiting now
• A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD) — Recruiting now
• A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk — Completed
• A Study to Evaluate the Efficacy and Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease — Completed
• Study of BMF-219 in Healthy Adult Subjects and in Adult Subjects With Type 2 Diabetes Mellitus (T2D) — Completed
• A Study to Evaluate EDP-235 in Non-hospitalized Adults With COVID-19 — Completed
• A Study to Assess EDP-938 for the Treatment of Acute Upper Respiratory Tract Infection With Respiratory Syncytial Virus in Adult Subjects — Completed
• Study to Determine the Safety and the Efficacy of Fasinumab Compared to Placebo and Nonsteroidal Anti-inflammatory Drugs (NSAIDs) for Treatment of Adults With Pain From Osteoarthritis of the Knee or Hip — Completed
• Efficacy, Safety, and Tolerability of Selonsertib (GS-4997) in Participants With Diabetic Kidney Disease — Completed
• A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Inadequately Controlled on Metformin Alone — Completed